Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina A Ganeeva

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Biology Research Communications|October 27, 2023
Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell lineAigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, et al.
Biomedicines|February 25, 2023
Evaluation of CAR-T Cells' Cytotoxicity against Modified Solid Tumor Cell LinesAigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, et al.
Biomedicines|April 27, 2024
Artificial Extracellular Vesicles Generated from T Cells Using Different Induction TechniquesEkaterina A Zmievskaya, Sabir A Mukhametshin, Irina A Ganeeva, et al.
Biomedicines|September 27, 2025
Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid TumorsSabir A Mukhametshin, Elvina M Gilyazova, Damir R Davletshin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Biology Research Communications|October 27, 2023
Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell lineAigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, et al.
Biomedicines|February 25, 2023
Evaluation of CAR-T Cells' Cytotoxicity against Modified Solid Tumor Cell LinesAigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, et al.
Biomedicines|April 27, 2024
Artificial Extracellular Vesicles Generated from T Cells Using Different Induction TechniquesEkaterina A Zmievskaya, Sabir A Mukhametshin, Irina A Ganeeva, et al.
Biomedicines|September 27, 2025
Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid TumorsSabir A Mukhametshin, Elvina M Gilyazova, Damir R Davletshin, et al.
Pageof 1